Key result
Monoamine oxidase inhibitor use for depression is increasing in Australia, necessitating awareness of associated prescribing problems and their implications for anesthesia.
Highlights the increasing use of MAO inhibitors in Australia and the associated implications for anaesthesia practice.
The use of monoamineoxidase inhibitors in the treatment of depression is increasing again in Australia. This paper outlines changes in prescribing, the problems associated with monoamineoxidase (MAO) inhibitors and how they relate to the practice of anaesthesia.
No takes yet. Share an insight, caveat, or question.
Brown et al. (1979) studied this question. Monoamine oxidase inhibitor use for depression is increasing in Australia, necessitating awareness of associated prescribing problems and their implications for anesthesia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: